Empirical Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$960K Buy
4,341
+2,391
+123% +$522K 0.01% 515
2026
Q2
$380K Sell
1,950
-1,020
-34% -$211K 0.01% 793
2026
Q1
$667K Sell
2,970
-72
-2% -$17.9K 0.01% 468
2025
Q4
$733K Sell
3,042
-2,674
-47% -$684K 0.01% 401
2025
Q3
$1.56M Sell
5,716
-18,989
-77% -$5.19M 0.03% 272
2025
Q2
$6.37M Buy
24,705
+1,025
+4% +$245K 0.14% 114
2025
Q1
$5.3M Buy
+23,680
New +$5.53M 0.14% 127
2022
Q1
– Sell
-1,901
Closed -$495K – 538
2021
Q4
$495K Sell
1,901
-1,186
-38% -$308K 0.02% 342
2021
Q3
$814K Buy
3,087
+499
+19% +$136K 0.05% 222
2021
Q2
$638K Buy
2,588
+1,494
+137% +$314K 0.04% 253
2021
Q1
$212K Buy
+1,094
New +$219K 0.02% 367

Other funds holding RMD

Empirical Wealth Management's RMD Position: Q3 2026 in Review

Empirical Wealth Management increased its ResMed (RMD) stake by 123% in Q3 2026, buying an estimated $522K and bringing the position to 4,341 shares worth $960K. The position accounts for 0.01% of the portfolio, ranked #515.

Empirical Wealth Management first reported a position in RMD in Q1 2021 and has held it in 11 quarters since. The position peaked at $6.37M in Q2 2025. 876 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Empirical Wealth Management held 4,341 shares of ResMed worth $960K as of Q3 2026.
  • Empirical Wealth Management bought 2,391 ResMed shares in Q3 2026, an estimated $522K.
  • ResMed made up 0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #515 holding.
  • Empirical Wealth Management first reported a position in ResMed in Q1 2021 and has held it in 11 quarters since.
  • Empirical Wealth Management's ResMed position peaked at $6.37M in Q2 2025.
  • 876 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.